Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates (DBD, NEOG, VIVO, ABAX)

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for Immucor Inc BLUD for the next year ending May, 2012 is $1.23 per share. BLUD's trailing-twelve-month operating margin is 39.07%. Neogen Corporation NEOG is expected to earn $1.13 per share over the next year ending May, 2012. NEOG's trailing-twelve-month ROE is 13.25%. Meridian Bioscience Inc VIVO is likely to earn $0.94 per share in the next year ending September, 2012. VIVO's trailing-twelve-month operating margin is 27.79%. ABAXIS Inc ABAX may earn $0.80 per share in the next year ending March, 2012. ABAX's PEG ratio is 1.97. Trading Ideas.